{"metadata": {"source": "erowid", "title": "Erowid MDMA Vault : Timeline", "description": "A timeline of events in the history of MDMA", "language": "No language found.", "url": "https://www.erowid.org/chemicals/mdma/mdma_timeline.php", "drug": "MDMA", "cid": 1615, "substance": "mdma", "category": "CHEMICALS", "erowid_column": "History", "char_count": 15085, "word_count": 2286, "doc_id": "doc_180", "num_chunks": 20, "chunk_id": "180::chunk_9", "document_index": 180, "latency_s": 1.2942725000029895, "prompt_toks": 4146, "completion_toks": 83, "relevance_score": 2.401054e-07}, "content": "Drug: MDMA | cid: 1615\nSource: erowid | Source description: A timeline of events in the history of MDMA\nErowid name: mdma\nCategory: CHEMICALS\nField: History\n\n                    Text: \n                    date and unknown/unsure names for two of the  three people (suggesting that he wasn't himself with them when they took the MDMA), and the fact that the dose in both descriptions was 100 mg for each  of the three people strongly suggests that *this* report from 1976 was what  sparked Sasha's interest in trying MDMA himself, and that it is this report that he described in PIHKAL. c. 1977 MDMA begins to be available on the street as a recreational drug. 10 1977 Great Britain amended its Misuse of Drugs Act (1971) to include as Class A all compounds structurally derived from an N-alkyl-alpha-methylphenethylamine by substitution in the ring with an alkylendioxy substituent. This legislation encompassed all ring substituted amphetamines (including MDA, MDE, MDMA, etc).\n\n\n                    Context: \n                    This excerpt details early recreational use and the historical emergence of MDMA, highlighting a 1976 report that inspired Alexander Shulgin's interest and its subsequent street availability around 1977. It also notes legislative changes in Great Britain in 1977 that classified MDMA and related compounds as controlled substances, emphasizing the drug's transition into illicit markets and legal regulation within the broader history of psychoactive substances covered in the document.\n                "}
{"metadata": {"source": "erowid", "title": "Erowid LSD (Acid) Vault : FAQ", "description": "Frequently Asked Questions about LSD", "language": "No language found.", "url": "https://www.erowid.org/chemicals/lsd/lsd_faq.shtml", "drug": "LSD", "cid": 5761, "substance": "lsd", "category": "CHEMICALS", "erowid_column": "FAQ", "char_count": 70642, "word_count": 10952, "doc_id": "doc_156", "num_chunks": 103, "chunk_id": "156::chunk_60", "document_index": 156, "latency_s": 0.9880808000016259, "prompt_toks": 16429, "completion_toks": 72, "relevance_score": 1.9444332e-07}, "content": "Drug: LSD | cid: 5761\nSource: erowid | Source description: Frequently Asked Questions about LSD\nErowid name: lsd\nCategory: CHEMICALS\nField: FAQ\n\n                    Text: \n                    insight, during a year in psychotherapy he managed to give up alcohol and start a promising business. But his anxiety continued, and in order to allay it he had to keep himself very busy wheeling and dealing. Imitating his father, a successful self-made man who had married a woman twenty years younger than himself, PQ dated only women under the age of nineteen. Being attractive to young women was so imporant to him that much of his time was spent in the company of teenagers. During business hours he would wear a conservative three-piece suit and drive a new sedan, but when he was with his young friends he would wear a leather jacket and drive a motorcycle. Anxiety and fears of inadequacy dominated both of these lives. Several months after therapy began, during a weekend in a small resort town, his young friends decided to take LSD, and he felt obliged to dissemble his fears and join them; it was his first and only trip. He felt a panic he had never known before; he thought that he was\n\n\n                    Context: \n                    This excerpt describes a individual's psychological background and personal life, including ongoing anxiety and behaviors aiming to cope with it, leading to their first and only LSD experience during therapy. It highlights the emotional state, social context, and a subsequent panic reaction, providing insight into the mental health and trip dynamics discussed within the overall document on psychedelics and their psychological effects.\n                "}
{"metadata": {"source": "psychonaut", "title": "Oxycodone - PsychonautWiki", "description": "Oxycodone (also known under brand names including Roxicodone, OxyContin, Percocet, Oxecta, OxyIR, Endone, Oxynorm, and OxyNEO) is a semi-synthetic opioid synthesized from poppy-derived thebaine. It is a narcotic analgesic within the morphinan chemical class and is generally indicated for relief of moderate to severe pain. It was developed in 1916 in Germany[2][3] as one of several new semi-synthetic opioids in an attempt to improve on the existing opioids.[4]", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Oxycodone", "drug": "Oxycodone", "cid": 5284603, "char_count": 20642, "word_count": 2894, "doc_id": "doc_88", "num_chunks": 28, "chunk_id": "88::chunk_25", "document_index": 88, "latency_s": 0.5753269999986514, "prompt_toks": 5623, "completion_toks": 46, "relevance_score": 1.2554204e-07}, "content": "Drug: Oxycodone | cid: 5284603\nSource: psychonaut | Source description: Oxycodone (also known under brand names including Roxicodone, OxyContin, Percocet, Oxecta, OxyIR, Endone, Oxynorm, and OxyNEO) is a semi-synthetic opioid synthesized from poppy-derived thebaine. It is a narcotic analgesic within the morphinan chemical class and is generally indicated for relief of moderate to severe pain. It was developed in 1916 in Germany[2][3] as one of several new semi-synthetic opioids in an attempt to improve on the existing opioids.[4]\n\n                    Text: \n                    ↑ Why Heroin Relapse Often Ends In Death - Lauren F Friedman (Business Insider) | http://www.businessinsider.com.au/philip-seymour-hoffman-overdose-2014-2\n\n↑ Siegel, S., Hinson, R. E., Krank, M. D., McCully, J. (23 April 1982). \"Heroin \"Overdose\" Death: Contribution of Drug-Associated Environmental Cues\". Science. 216 (4544): 436–437. doi:10.1126/science.7200260. ISSN 0036-8075.\n\n↑ 10.0 10.1 Ershad, M., Cruz, M. D., Mostafa, A., Mckeever, R., Vearrier, D., Greenberg, M. I. (March 2020). \"Opioid Toxidrome Following Grapefruit Juice Consumption in the Setting of Methadone Maintenance\". Journal of Addiction Medicine. 14 (2): 172–174. doi:10.1097/ADM.0000000000000535. ISSN 1932-0620.\n\n↑ VI.8a Convention for limiting the Manufacture and regulating the Distribution of Narcotic Drugs. Geneva, 13 July 1931 | https://treaties.un.org/doc/Treaties/1931/07/19310713%2006-44%20AM/Ch_VI_8_ap.pdf\n\n\n                    Context: \n                    This excerpt provides references and citations related to the dangers of heroin overdose, environmental factors influencing overdose risk, and international drug treaties, highlighting legal regulations and the complexities of opioid-related fatalities discussed in the full document on oxycodone.\n                "}
